Life Sciences

In the life sciences industry, the focus is increasingly shifting from pharmaceuticals or medical devices towards the patient and patient services. The development and implementation of customer-specific concepts and solutions along the life sciences value chain are key. At Eraneos, together with our life sciences customers, we implement and leverage digital technologies and transformation journeys so businesses can focus on having a greater impact on patients’ lives.

Eraneos Life Sciences propositions

Accelerated drug development and market access

Research and development (R&D) in the life sciences industry is facing some fundamental challenges. The creation of new drugs is taking more and more time and money.
 
New trends and paradigms are evolving to address these challenges, with digitalization being one of the most important. Taking advantage of digital technologies will provide opportunities to accelerate drug development while decreasing costs and time-to-market. It will also enable greater levels of patient-centricity and provide new therapeutic insights into pharmaceuticals by analyzing clinical data.

Integration and transparency are key

The digital integration of partners and customers along the supply chain, as well as the availability of real-time data to align demands with market supply, promises to mitigate some of the bottlenecks preventing life sciences companies from achieving their full potential. In addition, a timely response to changes in the market like supply shortages of raw materials is crucial.
 
Based on our expertise and industry best practices, we can provide the right technological and industry expertise to develop an agile and transparent end-to-end supply chain strategy. With the help of supply chain analytics, we enable our life science customers to react more quickly to events impacting their supply chain, thus allowing them to steer their business more proactively.